Special Investigation For Long Term Use Of Detrusitol (Regulatory Post Marketing Commitment Plan).

Trial Profile

Special Investigation For Long Term Use Of Detrusitol (Regulatory Post Marketing Commitment Plan).

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2012

At a glance

  • Drugs Tolterodine (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 06 Jul 2012 Primary endpoint amended and actual patient number change from 9 to 374 reported by ClinicalTrials.gov
    • 07 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top